Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v18-EN Version v16-EN
Language English English
Date Updated 2019-08-10 2019-08-09
Drug Identification Number 02245215 02245215
Brand name PYRIDOXINE HYDROCHLORIDE INJECTION, USP PYRIDOXINE HYDROCHLORIDE INJECTION, USP
Common or Proper name PYRIDOXINE PYRIDOXINE
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients PYRIDOXINE HYDROCHLORIDE PYRIDOXINE HYDROCHLORIDE
Strength(s) 100MG 100MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS
Packaging size 30 ML VIAL 30 ML VIAL
ATC code A11HA A11HA
ATC description OTHER PLAIN VITAMIN PREPARATIONS OTHER PLAIN VITAMIN PREPARATIONS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2019-07-31 2019-07-31
Actual start date 2019-08-08 2019-08-08
Estimated end date 2019-08-15 2019-08-15
Actual end date 2019-08-09 2019-08-09
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments